andrew ingersoll - national e-health transition authority (nehta) - australian medicines terminology...
TRANSCRIPT
![Page 1: Andrew Ingersoll - National E-Health Transition Authority (Nehta) - Australian Medicines Terminology (AMT) in eMM: need for innovation and research](https://reader034.vdocuments.net/reader034/viewer/2022052514/58efdfdf1a28abd67d8b4663/html5/thumbnails/1.jpg)
National E-Health Transition Authority www.nehta.gov.au1
Australian Medicines
Terminology (AMT) in eMM:
need for innovation and
research
5th Annual eMedication Management Conference
16 March 2016
Andrew Ingersoll Benefits and Evaluation Specialist
![Page 2: Andrew Ingersoll - National E-Health Transition Authority (Nehta) - Australian Medicines Terminology (AMT) in eMM: need for innovation and research](https://reader034.vdocuments.net/reader034/viewer/2022052514/58efdfdf1a28abd67d8b4663/html5/thumbnails/2.jpg)
2 National E-Health Transition Authority www.nehta.gov.au
• AMT as an enabler
• Ongoing implementations
• Need for innovation and research
Agenda
![Page 3: Andrew Ingersoll - National E-Health Transition Authority (Nehta) - Australian Medicines Terminology (AMT) in eMM: need for innovation and research](https://reader034.vdocuments.net/reader034/viewer/2022052514/58efdfdf1a28abd67d8b4663/html5/thumbnails/3.jpg)
3 National E-Health Transition Authority www.nehta.gov.au
Health system efficiencies
Population health outcomes
Why are we here?
AMT as an enabler
Avoidable adverse drug
events
Avoidable hospitalisations
![Page 4: Andrew Ingersoll - National E-Health Transition Authority (Nehta) - Australian Medicines Terminology (AMT) in eMM: need for innovation and research](https://reader034.vdocuments.net/reader034/viewer/2022052514/58efdfdf1a28abd67d8b4663/html5/thumbnails/4.jpg)
4 National E-Health Transition Authority www.nehta.gov.au
Computer and human readable language
AMT as an enabler
SNOMED CT
SNOMED CT-AU
AMT
![Page 5: Andrew Ingersoll - National E-Health Transition Authority (Nehta) - Australian Medicines Terminology (AMT) in eMM: need for innovation and research](https://reader034.vdocuments.net/reader034/viewer/2022052514/58efdfdf1a28abd67d8b4663/html5/thumbnails/5.jpg)
5 National E-Health Transition Authority www.nehta.gov.au
• Improved data quality
• Reduced time to sourcing information
• Reduction in transcription errors
• Capacity for analytics
• Intra and inter-organisational CDS
Benefits of AMT
AMT as an enabler
![Page 6: Andrew Ingersoll - National E-Health Transition Authority (Nehta) - Australian Medicines Terminology (AMT) in eMM: need for innovation and research](https://reader034.vdocuments.net/reader034/viewer/2022052514/58efdfdf1a28abd67d8b4663/html5/thumbnails/6.jpg)
6 National E-Health Transition Authority www.nehta.gov.au
Concepts
• Are objects of thought
• Designated by a unique code ConceptID
• Designed to cover medicines and their defining attributes
12809011000036105Amoxil 250 mg
capsule: hard, 20 27698011000036106acyclovir 200 mg tablet,
50 tablets(medicinal product pack)
21821011000036104codeine
(medicinal product) 35975011000036105Actonel Combi D (trade product)
AMT as an enabler
![Page 7: Andrew Ingersoll - National E-Health Transition Authority (Nehta) - Australian Medicines Terminology (AMT) in eMM: need for innovation and research](https://reader034.vdocuments.net/reader034/viewer/2022052514/58efdfdf1a28abd67d8b4663/html5/thumbnails/7.jpg)
7 National E-Health Transition Authority www.nehta.gov.au
AMT as an enabler
12809011000036105Amoxil 250 mg
capsule: hard, 20
21821011000036104codeine
(medicinal product)
35975011000036105Actonel Combi D (trade product)
![Page 8: Andrew Ingersoll - National E-Health Transition Authority (Nehta) - Australian Medicines Terminology (AMT) in eMM: need for innovation and research](https://reader034.vdocuments.net/reader034/viewer/2022052514/58efdfdf1a28abd67d8b4663/html5/thumbnails/8.jpg)
8 National E-Health Transition Authority www.nehta.gov.au
“the Commonwealth and all states and territories have a mutual interest in developing a national eHealth capability that will improve health outcomes and health system efficiency, and which is underpinned by national specifications, standards, services and infrastructure.”
Government commitment
Ongoing implementations
![Page 9: Andrew Ingersoll - National E-Health Transition Authority (Nehta) - Australian Medicines Terminology (AMT) in eMM: need for innovation and research](https://reader034.vdocuments.net/reader034/viewer/2022052514/58efdfdf1a28abd67d8b4663/html5/thumbnails/9.jpg)
9 National E-Health Transition Authority www.nehta.gov.au
• Migration to AMT
• AMT integrated into priority specifications and services; and
• Taking steps towards incorporating AMT into new clinical systems and upgrades
AMT called out as a priority
Ongoing implementations
![Page 10: Andrew Ingersoll - National E-Health Transition Authority (Nehta) - Australian Medicines Terminology (AMT) in eMM: need for innovation and research](https://reader034.vdocuments.net/reader034/viewer/2022052514/58efdfdf1a28abd67d8b4663/html5/thumbnails/10.jpg)
10 National E-Health Transition Authority www.nehta.gov.au
Ongoing implementations
WA
NTQLD
NSW
ACTVIC
TAS
SA
12809011000036105Amoxil 250 mg
capsule: hard, 20
35975011000036105Actonel Combi D (trade product)
![Page 11: Andrew Ingersoll - National E-Health Transition Authority (Nehta) - Australian Medicines Terminology (AMT) in eMM: need for innovation and research](https://reader034.vdocuments.net/reader034/viewer/2022052514/58efdfdf1a28abd67d8b4663/html5/thumbnails/11.jpg)
11 National E-Health Transition Authority www.nehta.gov.au
• Eliminate paper and free text
• Eliminate silos with eHealth solutions
• Extractable data
• eHealth infrastructure as platforms for innovation
• Positively disrupt workflows
Changes required
Ongoing implementations
![Page 12: Andrew Ingersoll - National E-Health Transition Authority (Nehta) - Australian Medicines Terminology (AMT) in eMM: need for innovation and research](https://reader034.vdocuments.net/reader034/viewer/2022052514/58efdfdf1a28abd67d8b4663/html5/thumbnails/12.jpg)
12 National E-Health Transition Authority www.nehta.gov.au
• Assess and validate assumptions
• Inform resource decisions
• Communicate successes
• Measure ROI
• Secure commitment to ongoing funding
Why measure?
Need for innovation and research
![Page 13: Andrew Ingersoll - National E-Health Transition Authority (Nehta) - Australian Medicines Terminology (AMT) in eMM: need for innovation and research](https://reader034.vdocuments.net/reader034/viewer/2022052514/58efdfdf1a28abd67d8b4663/html5/thumbnails/13.jpg)
13 National E-Health Transition Authority www.nehta.gov.au
Longitudinal – impact of eHealth solutions over time
Retrospective – impact of past eHealth implementations
Baseline – pre implementation, gain ability to measure the impact after an upcoming implementation
Research with impact
Need for innovation and research
![Page 14: Andrew Ingersoll - National E-Health Transition Authority (Nehta) - Australian Medicines Terminology (AMT) in eMM: need for innovation and research](https://reader034.vdocuments.net/reader034/viewer/2022052514/58efdfdf1a28abd67d8b4663/html5/thumbnails/14.jpg)
14 National E-Health Transition Authority www.nehta.gov.au
• AMT is the language of medicines
• AMT enables cross sector clinical decision support
• Innovation and research are required
Review
12809011000036105Amoxil 250 mg
capsule: hard, 20
21821011000036104codeine
(medicinal product)
35975011000036105Actonel Combi D (trade product)
![Page 15: Andrew Ingersoll - National E-Health Transition Authority (Nehta) - Australian Medicines Terminology (AMT) in eMM: need for innovation and research](https://reader034.vdocuments.net/reader034/viewer/2022052514/58efdfdf1a28abd67d8b4663/html5/thumbnails/15.jpg)
15 National E-Health Transition Authority www.nehta.gov.au
• Baseline study
• Aged Care and General Practice
• Role for AMT in cross sector medicine information exchange
GRACE Med